Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma
Martina Mang Leng Lei(Hong Kong Polytechnic University), Terence K. Lee(Hong Kong Polytechnic University)
Cited by 3
Related Papers
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
|Nature Reviews Gastroenterology & Hepatology|2021|472
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
|Cancer Research|2021|130
FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation
|Carcinogenesis|2004|79
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
|Nature Communications|2023|47
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma
|Cell Reports Medicine|2025|42